| Bid price | 19.00 | Open price | 19.25 |
|---|---|---|---|
| Ask price | 20.00 | Prev close | 19.50 |
| High price | 20.70 | Spread | 5.00% |
| Low price | 19.00 | Volume | 18,541 |
Register now for FREE live Vernalis share prices, Vernalis stock quotes, charts, trades and FREE Vernalis company fundamentals, market news and much much more. Why not upgrade to a premium service and get Vernalis Level 2 Data, indepth research tools and investor commentary for Vernalis (VER) and other London Stock Exchange equities.
Register now for FREE Vernalis share price charts
| Name | Vernalis | Epic | VER |
|---|---|---|---|
| Activites | Develops and commercializes pharmaceutical products for a range of medical disorders. | Reuters | VER.L |
| ISIN | GB00B3Y5L754 | Google Finance | LON:VER |
| Share Price (p) | 19.50 | Prev. Share Price (p) | 19.50 |
|---|---|---|---|
| Shares in Issue (m) | 100 | Market Cap (£m) | 19 |
| PE Ratio (x) | -1.91 | Div per share (p) | 0.00 |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | -21.10 | PEG |
Register now for FREE Vernalis company fundamentals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 17/08/2011 | BUY | Allan Baxter | NED | 25,000 |
| 12/08/2011 | BUY | Ian Garland | CEO | 50,000 |
| 12/08/2011 | BUY | David Mackney | FD | 50,000 |
| 01/06/2010 | BUY | George Kennedy | NED | 100,000 |
| 13/05/2009 | BUY | Ian Garland | CEO | 1,111,100 |
Vernalis and Servier have entered into a new three-year joint oncology collaboration focused on the discovery of drugs for a new undisclosed target. The collaboration will utilise Vernalis' proprietary fragment and structure-based drug discovery platform and Vernalis will receive fees and a...
Story provided by StockMarketWire.com
/* */ RNS Number : 6523V Vernalis PLC 17 January 2012 LSE: VER Vernalis and Servier Sign Third Oncology Collaboration Vernalis plc, Winnersh, UK and Servier, Suresnes, France - January 17, 2012 announce they have...
Register now for FREE Vernalis company news
This is for 2008 -9 (2007 was a year with great hopes and hype, equals a sp about 50p) Reality now is a sp about 4p Yet despite a drug failure ( was it?), they have some products that look interesting - not earth-shattering but a decent pipeline AND some CASH - "wow"! the only Q in my...
Surely the answer from FDA is going to be yes!
Register now for FREE Vernalis share price discussions